Announcements Trials
Browse Landscape

Status

Completed 9Withdrawn 2Unknown 2Terminated 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Leukemia 3Endometrial Neoplasms 2Breast Neoplasms 2Pituitary Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Congenital Abnormalities 1

Interventions

Cyclophosphamide 76Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 46Epirubicin 46Letrozole 42pyrotinib 40Fulvestrant 36Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 31exemestane 27Anastrozole 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 19Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT01420185 2015-05-08

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

NSABP Foundation Inc

Unknown
1,300 enrolled
Breast

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
120 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡